5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Thyrocare Technologies Ltd.

•
thyrocare.comBSE: 539871NSE: THYROCARE
Market Cap₹ 9,034 Cr.
Current Price
High / Low₹ 662 / 343
Stock P/E51.2
Book Value₹ 40
Price to Book9.62
Dividend Yield2.47 %
ROCE38.3 %
ROE29.0 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Diagnostic Testing Service: 93.2% • Imaging Service: 6.4% • Others: 0.4%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 28.1%
  • Company has consistently been profitable over the last 5 years
  • Latest quarter profit grew 34.1% YoY, showing strong momentum
  • Operating margins have improved to 29.7% from 24.9%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.74x)

CONS

  • Promoter holding has decreased over last 2 years: -10.2pp
  • Stock is trading at 9.6x its book value
  • Company has delivered a poor profit growth of 7.6% over past five years
  • Valuation is stretched - P/E of 51.2 is well above its own 5-year median (34.1)
  • Dividend payout exceeds earnings (136.4%) - may be unsustainable

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY MICROCAP250NIFTY TOTAL MKT
S.No.Name
1.APOLLOHOSP8960.0061.66128831.050.22610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1036.5069.24100883.610.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS729.95107.6096015.960.002434.30—30906.30—13.9323.83
4.FORTIS911.9065.7068844.630.11272.802.262545.0317.4614.0721.28
5.ASTERDM780.05213.3667994.810.0029.28-68.701310.6821.6011.4619.53
6.MEDANTA1479.7571.5439786.300.03157.25-1.091304.0526.5019.3821.99
7.NH1888.8047.3038599.670.24207.275.372683.6378.0516.2017.43
8.LALPATHLAB1919.4559.4532217.741.071705.001172.397977.001090.9529.5631.03
9.KIMS764.80157.2332122.100.0037.40-56.001179.5035.3311.5119.03
10.AGARWALEYE514.20109.8716301.490.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1496.8582.2315417.210.1353.1037.61230.9822.8330.2842.66
12.THYROCARE567.6051.249034.222.47513.301240.562400.201143.4338.3032.49
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
1351481351541571771661871932171962242,400
1001101031201141291241291351451381491,766
Operating Profit353832344348425858715875634
OPM %25.58%25.35%23.45%21.92%27.17%27.23%25.15%30.83%29.93%32.95%29.58%33.53%26.43%
1233434553-1442
Interest1111111111-0214
Depreciation101113131113171411122214125
Profit before Tax252820233437284850623564683
Tax %30.87%28.45%26.14%24.74%28.34%27.95%31.94%53.58%24.27%23.71%20.91%24.64%24.84%
Net Profit00002426192238482849513
3.263.842.783.544.524.991.151.397.359.051.822.993.23

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
3043564034344955895275726878293,036
1892122492613233534044334975832,198
Operating Profit115145154174171236123139191246839
OPM %37.91%40.62%38.28%39.97%34.62%40.03%23.27%24.26%27.72%29.66%27.62%
-1521100122989152848
Interest001213564416
Depreciation18202632303439475559172
Profit before Tax821451381401522288996145213844
Tax %47.54%35.66%38.33%37.04%25.79%22.65%27.35%27.60%37.60%23.50%24.57%
Net Profit43938588113176646991163637
EPS8.1317.3415.9116.7121.3733.2512.1413.4217.1210.27—
Dividend Payout %125.21%57.49%123.85%29.85%118.27%45.07%144.31%134.15%122.64%136.36%—

COMPOUNDED SALES GROWTH

10 Years:
13%
5 Years:
11%
3 Years:
16%

COMPOUNDED PROFIT GROWTH

10 Years:
12%
5 Years:
8%
3 Years:
35%

STOCK PRICE CAGR

10 Years:
11%
5 Years:
6%
3 Years:
43%
1 Year:
29%

RETURN ON EQUITY

10 Years:
21%
5 Years:
22%
3 Years:
20%
Last Year:
29%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2025

Nov 28

2:1

Quarterly Results & Interim Dividend & Bonus issue

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital545453535353535353159
Minority Interest0000001101
349387378310371470477469489420
71012851616251739
Trade Payables17822251724407665
23171976852921904196105
Total Liabilities434474470469540848761629732789
259299294269253285294306297317
Capital Work in Progress170158323143
1041209590126146144162162177
14171821232528484748
0000000437374
Cash & Bank12121011161428405468
272651731143752652785101
Total Assets434474470469540848761629732789

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
130156161212158170158168180213
Cash from Investing-42-43-121-49-24-39-91-41-23
Cash from Financing-49-64-94-165-62-89-86-85-130-170
-0-0-54404-8821

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
71.1171.1171.0671.0671.0671.0660.9360.9260.92
2.491.932.772.413.234.854.965.375.43
14.8914.7914.6814.9714.5413.4720.5221.0020.92
Government0.000.000.000.000.000.000.000.000.00
11.4912.1611.5011.5611.1710.6313.6112.7112.72

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Disclosure under SEBI Takeover Regulations

2026-09-04 - API Holdings limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

2026-09-04
Copy of Newspaper Publication

2026-09-04 - Thyrocare Technologies Limited has informed the Exchange about Copy of Newspaper Publication pertaining to Notice of transfer of equity shares of the Company to Investor Education and Protection Fund.

2026-09-01
Updates

2026-09-01 - Thyrocare Technologies Limited has informed the Exchange regarding Communication Received from API Holdings Limited regarding Approval of Scheme of Amalgamation of Docon Technologies Private Limited with API Holdings Limited

2026-08-19
General Updates

2026-08-19 - Thyrocare Technologies Limited has informed the Exchange regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited

2026-08-18
Disclosure under SEBI Takeover Regulations

2026-08-18 - Thyrocare Technologies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

2026-08-18
Disclosure under SEBI Takeover Regulations

2026-08-18 - Docon Technologies Private Ltd has submitted to  the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

2026-08-17
Updates

2026-08-17 - Thyrocare Technologies Limited has informed the Exchange regarding 'Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited'.

2026-08-13
Updates

2026-08-13 - Thyrocare Technologies Limited has informed the Exchange regarding communication received from Promoter regarding sale of 1,57,69,696 Equity Shares of the Company by Promoter - Docon Technologies Private Limited.

2026-08-13
Updates

2026-08-13 - Thyrocare Technologies Limited has informed the Exchange regarding a Communication Received From Promoter Regarding Release Of Pledge On 1,75,00,000 Equity Shares of the Company

News

Recent coverage and analyst commentary for THYROCARE

Loading news…

🤖

AI Stock Analyst

Thyrocare Technologies Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login